Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Summit Therapeutics Inc (SMMT) vs SYSCO Corporation (SYY) Price & Performance

Summit Therapeutics IncTrade
SYSCO CorporationTrade

Price performance (Past 24H)

Key statistics

Summit Therapeutics Inc vs SYSCO Corporation — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while SYSCO Corporation trades at $81.33 (market cap $38.63B). The key difference: SYSCO Corporation is far larger — about 3.7× Summit Therapeutics Inc's market cap, and SYSCO Corporation pays a 2.72% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.

SMMTSYY
Market Cap
$10.48B$38.63B
Sector
HealthConsumer Staples
52-Week High
$29.32$91.16
52-Week Low
$13.05$69.30
Enterprise Value
$9.90B$52.11B
Dividend Yield
2.72%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Read more on SMMT

About SYSCO Corporation

Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.

Read more on SYY